Statins, Ezetimibe, and Proprotein Convertase Subtilisin–Kexin Type 9 Inhibitors to Reduce Low-Density Lipoprotein Cholesterol and Cardiovascular Events-Reference-Cited by-同舟云学术

Statins, Ezetimibe, and Proprotein Convertase Subtilisin–Kexin Type 9 Inhibitors to Reduce Low-Density Lipoprotein Cholesterol and Cardiovascular Events

Published:2017-02 Issue:4 Volume:119 Page:565-571
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

O'Keefe James H.^ORCID,DiNicolantonio James J.,Lavie Carl J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study;Jaffer;Arterioscler Thromb Vasc Biol,2002

2. Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal;O'Keefe;J Am Coll Cardiol,2004

3. Cardiovascular disease resulting from a diet and lifestyle at odds with our Paleolithic genome: how to become a 21st-century hunter-gatherer;O'Keefe;Mayo Clin Proc,2004

4. Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote;Zhao;Am J Hum Genet,2006

5. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis;Ference;J Am Coll Cardiol,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persons With Human Immunodeficiency Virus;Clinical Lipidology;2024

2. Geographic and ethnic variations in response to lipid-lowering therapies: why do they matter?;European Journal of Preventive Cardiology;2023-04-17

3. Flavonoids extract from the seeds of Psoralea corylifolia L. (PFE) alleviates atherosclerosis in high-fat diet-induced LDLR−/− mice;Phytomedicine;2022-04

4. Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives;Molecular Pharmaceutics;2022-03-25

5. High-Intensity Statin vs. Low-Density Lipoprotein Cholesterol Target for Patients Undergoing Percutaneous Coronary Intervention: Insights From a Territory-Wide Cohort Study in Hong Kong;Frontiers in Cardiovascular Medicine;2021-10-28